ANIK - Anika Therapeutics Inc

https://www.anika.com

Strong Sell Momentum: Bearish

Recent News

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )

GlobeNewswire • 1 week, 3 days ago • score: 0.43

BEDFORD, Mass., Sept. 05, 2025 ( GLOBE NEWSWIRE ) -- Anika Therapeutics, Inc. ( NASDAQ: ANIK ) , a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on September 2, 2025, Anika granted ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

As of 2025-09-10 (Snapshot)

Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally. The company is headquartered in Bedford, Massachusetts.

52W High

$26.00

52W Low

$7.87

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.63

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

49.75

EV/EBITDA (<8 favorable)

175.12

EV/Revenue (<3 favorable)

0.88

P/S (TTM) (<3 favorable)

1.13

P/B (<3 favorable)

0.87

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

4.89%

Institutions (25–75% balanced)

89.35%

Shares Outstanding

14,418,100

Float

10,362,600

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

114,548,000

Gross Profit (TTM)

66,184,000

EPS (TTM)

-0.90

Profit Margin (>10% good)

-0.53%

Operating Margin (TTM) (higher better)

-0.15%

ROE (TTM) (>15% strong)

-0.07%

EPS YoY (Quarterly) (>10% good)

-0.51

Revenue YoY (Quarterly) (>8% good)

-0.08

Momentum

Bearish momentum

Value

-0.2411

-0.2406

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025